| Literature DB >> 30846101 |
Eric Van Belle1, Flavien Vincent1, Antoine Rauch2, Caterina Casari3, Emmanuelle Jeanpierre2, Valentin Loobuyck4, Mickael Rosa5, Cedric Delhaye6, Hughes Spillemaeker6, Camille Paris2, Nicolas Debry6, Basile Verdier6, André Vincentelli4, Annabelle Dupont5, Peter J Lenting3, Sophie Susen7.
Abstract
For decades, numerous observations have shown an intimate relationship between von Willebrand factor (VWF) multimer profile and heart valve diseases (HVD). The current knowledge of the unique biophysical properties of VWF helps us to understand the longstanding observations concerning the bleeding complications in patients with severe HVD. Not only does the analysis of the VWF multimer profile provide an excellent evaluation of HVD severity, it is also a strong predictor of clinical events. Also of importance, VWF responds within minutes to any significant change in hemodynamic valve status, making it an accurate marker of the quality of surgical and transcatheter therapeutic interventions. The authors provide in this review a practical, comprehensive, and evidence-based framework of the concept of VWF as a biomarker in HVD, advocating for its implementation into the clinical decision-making process besides usual clinical and imaging evaluation. They also delineate critical knowledge gaps and research priorities to definitely validate this concept.Entities:
Keywords: aortic stenosis; biomarker; bioprosthesis heart valve disease; mitral regurgitation; paravalvular regurgitation; point-of-care test; transcatheter aortic valve replacement; von Willebrand factor
Mesh:
Substances:
Year: 2019 PMID: 30846101 DOI: 10.1016/j.jacc.2018.12.045
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094